机构:[1]Department of Neurology, Peking University Third Hospital, Beijing, China.[2]Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.神经科系统神经内科首都医科大学宣武医院[3]Beijing Key Laboratory of Biomarker and Translational Research in Neurodegenerative Diseases, Beijing, China, and.[4]Key Laboratory for Neuroscience, National Health Commission/Ministry of Education, Peking University, Beijing, China.
Mirror movements (MMs) are often overlooked in patients with amyotrophic lateral sclerosis (ALS). Although the contralateral co-movement (COMO) test can be used to evaluate MMs in patients with ALS, it lacks a systematic evaluation. The aim of this study was to validate the effectiveness of the Chinese version of the COMO test in a Chinese ALS population.We prospectively enrolled 173 patients with ALS as the disease group and 28 healthy individuals as controls. All participants were evaluated using the Chinese version of the COMO test. Univariate analysis and multiple linear regression were used to compare differences between groups. Subgroup analysis of the COMO scores was performed based on different disease characteristics.The COMO score in the ALS group was significantly greater (5.00% [1.67-10.00]) than that in the healthy control group (1.67% [0.00-3.33]). After adjusting for confounders, this difference remained significant. Multivariate linear analysis suggested that the upper motor neuron (UMN) score independently predicted the COMO score (P < 0.001). The COMO score was not affected by different onset regions or lateralizations. Propensity score matching revealed no significant difference in COMO scores between uninvolved limb segments and the corresponding limb segments in other patients. The Cronbach's α of the Chinese COMO test was 0.621.The Chinese COMO test can serve as a potential tool for assessing MMs in Chinese patients with ALS. The UMN score is a factor influencing the COMO score. The COMO test can provide objective evidence for ALS characteristics and the severity of UMN damage.
基金:
This work was supported by the National Natural
Science Foundation of China (grant Nos.
82001350, 82071426, and 81873784), the Clinical
Cohort Construction Program of Peking
University Third Hospital (grant No.BYSYDL2019002), Peking University Third
Hospital Clinical Key Projects
(BYSYZD2024007), Peking University Third
Hospital Fund for Interdisciplinary Research
(BYSYJC2024017) and the Beijing E-Town
Cooperation & Development Foundation (grant
Nos. YJXJ-JZ-2021-0014 and YCXJ-JZ-
2022-007).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2024]版:
无
最新[2023]版:
大类|4 区医学
小类|4 区临床神经病学
第一作者:
第一作者机构:[1]Department of Neurology, Peking University Third Hospital, Beijing, China.[2]Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
通讯作者:
通讯机构:[1]Department of Neurology, Peking University Third Hospital, Beijing, China.[3]Beijing Key Laboratory of Biomarker and Translational Research in Neurodegenerative Diseases, Beijing, China, and.[4]Key Laboratory for Neuroscience, National Health Commission/Ministry of Education, Peking University, Beijing, China.
推荐引用方式(GB/T 7714):
Wu Jieying,Sun Can,Xu Yingsheng,et al.The contralateral co-movement test in a Chinese population with amyotrophic lateral sclerosis[J].Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration.2025,1-10.doi:10.1080/21678421.2025.2467959.
APA:
Wu Jieying,Sun Can,Xu Yingsheng,Fan Dongsheng&Ye Shan.(2025).The contralateral co-movement test in a Chinese population with amyotrophic lateral sclerosis.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration,,
MLA:
Wu Jieying,et al."The contralateral co-movement test in a Chinese population with amyotrophic lateral sclerosis".Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration .(2025):1-10